Connecticut Confirms First U.S. Clade I Mpox Case After Western Europe Travel

11 articles · Updated · Fox News · May 14

Connecticut health officials confirmed the first U.S. clade I mpox case in a resident who recently traveled to Western Europe.
CDC-backed guidance says the case poses no risk to the general public, but officials urged people at higher risk to get the two-dose JYNNEOS vaccine before summer travel and gatherings.
Clade I is genetically distinct from the clade II virus that drove the 2022 global outbreak and has been linked to more severe illness, broader rashes and higher mortality.
The case adds to health agencies’ focus on travel-related infectious disease surveillance as international movement rises.

A rare hantavirus outbreak on a cruise ship hints at person-to-person spread. How prepared are we for this possibility?

With a more severe mpox strain spreading, why is there a critical immunity gap in the most vulnerable communities?

As deadlier mpox strains and rare viruses emerge, are our advanced epidemic warning systems actually protecting us?